Empowering Patients to Choose the Right HIV PrEP for Them
Apr 25, 2023•13 min•Ep. 90
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including:
- Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF
- Differences in adverse effect profiles between 4 PrEP options
- Potential for HIV resistance
- Requirements for compliance and monitoring
- Evidence in populations with various acquisition behaviors
- Drug interaction implications
Faculty:
Jona Tanguay, MMSc, PA-C, AAHIVS
Health Care Provider and HIV Specialist
Whitman-Walker Health
Vice President for Education, GLMA: Health Professionals Advancing LGBTQ Equality
Clinical Instructor, Yale University School of Nursing
Washington, DC
Link to full program: https://bit.ly/41WF54o
For the best experience, listen in Metacast app for iOS or Android